International life sciences · GCC market entry

From global innovation
to GCC execution.

Connect your pharmaceutical, biotechnology or medtech programme to a clear plan for the UAE, Saudi Arabia and wider GCC. Bring scientific evidence, regulatory readiness, market access and operational delivery into one conversation.

Find your country and language ↓

Start with the decision your team needs to make.

HERMS combines specialist workflows with its connected intelligence platform. The right starting point depends on your product, existing evidence, intended markets and delivery model.

Assess the regulatory gap

Organise the product, dossier, manufacturing-site and lifecycle questions that need a documented assessment before a submission plan is agreed.

Explore regulatory affairs →

Plan safe execution

Bring pharmacovigilance, compliance, quality, supply-chain and partner responsibilities into the operating model from the beginning.

Explore the connected solutions →

Where is your team based?

Choose a language to explore HERMS, or begin a GCC programme discussion from your country. These links describe the intended audience; HERMS is based in Dubai, UAE.

Language links open the existing HERMS website editions. Programme scope, working language and delivery arrangements are agreed during scoping.

Make the first discussion productive.

A useful starting brief contains six items. Share non-confidential information first; agree a suitable confidentiality arrangement before exchanging sensitive programme material.

  1. Your product: category, development stage and the decision you need to make.
  2. Your intended markets: the GCC countries under consideration and the reason for prioritising them.
  3. Your evidence: a high-level inventory of existing clinical, quality, safety and value materials.
  4. Your delivery model: manufacturing, distribution, local partner and technology-transfer considerations.
  5. Your timeline: business milestones, dependencies and any known constraints.
  6. Your success measures: the outputs, decision gates and outcomes that would make the engagement useful.

A focused demonstration starts with your workflow.

For advanced therapies, explore GENIX and CELLIX. For innovation screening and diligence, explore VALNEXIS and VERIQIS. For transfer and manufacturing workflows, explore INNEXIS and SYNTRIX.

Find the relevant HERMS solution →

Prepare your GCC launch discussion.

Evidence and access

Connect the proposed product value to the commercial and evidence questions your launch team needs to resolve.

Read the market-access guide →

Partnerships

Discuss scientific, technology, implementation and commercial collaboration with HERMS.

Explore partnerships →

ENGINEERING INTELLIGENCE. REVOLUTIONIZING LIFE SCIENCES.

HERMS is the intelligence platform. Its applications are the decision engines. HERMS expert services support implementation and regulated execution of the HERMS intelligence ecosystem, from regulatory and market access to pharmacovigilance, compliance and quality.

Drug registration timelines by country · SFDA, MOHAP, EDE, EDA, EMA and FDA timelines · GCC central registration